Good’s综合征合并新型冠状病毒感染一例及文献复习

明君 闫(承德医学院附属医院呼吸与危重症医学科，中国)
志伟 赵(承德医学院附属医院呼吸与危重症医学科，中国)

摘要

Good’s综合征（Good’s syndrome，GS）是罕见成年发病的原发性免疫缺陷综合征，以体液免疫和细胞免疫缺陷为主要表现，以胸腺瘤、低丙种球蛋白血症、CD4+/CD8+T淋巴细胞比值下降（倒置）、低外周血B细胞和伴有CD4+T淋巴细胞免疫缺陷为特点。新型冠状病毒感染（COVID-19）是由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的肺部感染。近几年的大流行已在全球范围内构成严重的公共卫生威胁。GS患者免疫功能缺陷，是新型冠状病毒感染重症/危重症的高危人群。GS合并新型冠状病毒感染国内目前尚无报道，现将笔者科室诊治的1例GS合并新型冠状病毒感染进行报道，结合文献进行分析，以提高临床医生对GS合并新型冠状病毒感染的认识。

关键词

Good’s综合征；新型冠状病毒感染；免疫缺陷

参考

Good RA. Agammaglobulinemia-a provocative experiment of nature[J]. Bull University Minn Hosp Minn Med Fdn, 1954(26):1-19.

中华人民共和国国家卫生健康委员会.新型冠状病毒感染诊疗方案(试行第十版)[J].中国合理用药探索,2023,20(1):1-11.

Kelesidis T,Yang O. Good’s syndrome remains a mystery after 55 years: A systematic reviewof of the scientific evidence[J]. Clin Immunol, 2010,135(3):347-363.

Kabir A, Alizadehfar R, Tsoukas CM. Good’s Syndrome: Time to Move on From Reviewing the Past[J]. Front Immunol, 2022(12):815710.

Guevara-Hoyer K, Fuentes-Antrás J, Calatayud Gastardi J, et al. Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin[J]. Immunol Lett, 2021(231):11-17.

刘爽,周宇麒.腹泻、气促伴消瘦1例——Good’s综合征[J].临床肺科杂志,2023,28(2):321-324.

汪超,翟丽丽,王洋.以反复呼吸系统感染为主要表现的Good综合征一例[J].中华肺部疾病杂志(电子版),2022,15(6):920-922.

Shi Y,Wang C. When the Good Syndrome Goes Bad: A Systematic Literature Review[J]. Front Immunol, 2021(12): 679556.

Dong JP, Gao W, Teng GG, et al. Characteristics of Good’s Syndrome in China: A Systematic Review[J]. Chin Med J (Engl), 2017, 130(13): 1604-1609.

Shi Y, Wang C. When the Good Syndrome Goes Bad: A Systematic Literature Review[J]. Front Immunol, 2021(12): 679556.

Deng Q, Yan Z, Yang Y, et al. Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome[J]. J Neurovirol, 2022, 28(1):177-180.

林炳棋,殷建团.Good’s综合征1例[J].临床肺科杂志,2019,24(1):189-191.

Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)[J]. Postgrad Med J, 2020, 96(1142): 753-758.

Lee S, Ryu JH. Influenza Viruses: Innate Immunity and mRNA Vaccines[J]. Front Immunol, 2021(12):710647.

Primorac D, Vrdoljak K, Brlek P, et al. Adaptive Immune Responses and Immunity to SARS-CoV-2[J]. Front Immunol, 2022(13):848582.

Duarte M, Faria L, Patronillo C, et al. A Case of Severe COVID-19 in a Patient with Good’s Syndrome[J]. Eur J Case Rep Intern Med, 2021, 8(10): 2976.

Maldonado-Domínguez ED, O Farrill-Romanillos PM. Patient with Good’s syndrome and COVID-19. Report of a clinical case[J]. Rev Med Inst Mex Seguro Soc, 2022,60(4):474-479.

Cos Esquius ML, López Montesinos I, Gimeno Martinez R, et al. Severe COVID-19 pneumonia in Good syndrome with a favorable outcome[J]. Clin Immunol,2022(235):108789.

Wee LE, Tan JY, Oon LLE, et al. Relapsing COVID-19 infection as a manifestation of Good’s syndrome: a case report and literature review[J]. Int J Infect Dis, 2023(129):236-239.

Pozzi MR, Baronio M, Janetti MB,et al. Fatal SARS-CoV-2 infection in a male patient with Good’s syndrome[J]. Clin Immunol, 2021(223):108644.

López AL, Torre MG, Paolini MV, et al. COVID-19 in adults with antibody deficiencies[J]. Medicina (B Aires), 2021,81(3):478-481.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i1.15601